Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2180 GBX | -3.11% | -3.11% | -63.67% |
08-14 | Distil seeks urgent funding after revenue halves | AN |
08-14 | Stocks stay upbeat ahead of US CPI data | AN |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.37 | 4.11 | -0.67 | -6.32 | -7.5 | |||||
Return on Total Capital | 3.48 | 4.39 | -0.73 | -7 | -8.45 | |||||
Return On Equity % | 7.81 | 9.48 | 3.06 | -10.43 | -17.72 | |||||
Return on Common Equity | 7.81 | 9.48 | 3.06 | -10.43 | -17.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 59.24 | 55.59 | 55.37 | 51.82 | 48.33 | |||||
SG&A Margin | 51.7 | 48.56 | 57.61 | 112.73 | 106.76 | |||||
EBITDA Margin % | 8.07 | 7.44 | -1.7 | -59.7 | -57.26 | |||||
EBITA Margin % | 7.54 | 7.02 | -2.24 | -60.91 | -58.44 | |||||
EBIT Margin % | 7.54 | 7.02 | -2.24 | -60.91 | -58.44 | |||||
Income From Continuing Operations Margin % | 10.57 | 9.49 | 5.91 | -56.67 | -76.62 | |||||
Net Income Margin % | 10.57 | 9.49 | 5.91 | -56.67 | -76.62 | |||||
Net Avail. For Common Margin % | 10.57 | 9.49 | 5.91 | -56.67 | -76.62 | |||||
Normalized Net Income Margin | 4.66 | 4.2 | -0.62 | -30.97 | -30.37 | |||||
Levered Free Cash Flow Margin | -9.31 | 3.12 | 1.59 | -52.31 | -47.42 | |||||
Unlevered Free Cash Flow Margin | -9.26 | 3.31 | 1.59 | -52.31 | -47.42 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.71 | 0.94 | 0.48 | 0.17 | 0.21 | |||||
Fixed Assets Turnover | 17.31 | 22.6 | 17.62 | 8.25 | 10.33 | |||||
Receivables Turnover (Average Receivables) | 8.36 | 7.75 | 5.83 | 1.99 | 2.53 | |||||
Inventory Turnover (Average Inventory) | 3.01 | 3.56 | 2.21 | 0.75 | 0.69 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 13.89 | 6.21 | 5.18 | 2.66 | 3.47 | |||||
Quick Ratio | 10.98 | 4.47 | 3.83 | 1.55 | 1.58 | |||||
Operating Cash Flow to Current Liabilities | -0.79 | 0.71 | -0.27 | -0.96 | -1.53 | |||||
Days Sales Outstanding (Average Receivables) | 43.78 | 47.09 | 62.59 | 183.33 | 144.91 | |||||
Days Outstanding Inventory (Average Inventory) | 121.57 | 102.5 | 165.4 | 489.54 | 528.77 | |||||
Average Days Payable Outstanding | 26.24 | 30.55 | 59.7 | 147.81 | 194.1 | |||||
Cash Conversion Cycle (Average Days) | 139.11 | 119.04 | 168.29 | 525.05 | 479.58 | |||||
Long Term Solvency | ||||||||||
Total Liabilities / Total Assets | 3.54 | 8.6 | 6.87 | 12.86 | 9.47 | |||||
EBIT / Interest Expense | 92 | 23.09 | - | - | - | |||||
EBITDA / Interest Expense | 123 | 24.45 | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | 104.5 | 21.82 | - | - | - | |||||
Net Debt / EBITDA | -3.49 | -3.95 | 31.24 | 0.91 | 0.6 | |||||
Net Debt / (EBITDA - Capex) | -4.11 | -4.42 | 23.67 | 0.91 | 0.6 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.67 | 48.14 | -18.64 | -55.13 | 15.38 | |||||
Gross Profit, 1 Yr. Growth % | 1.19 | 39 | -18.96 | -58.01 | 7.6 | |||||
EBITDA, 1 Yr. Growth % | 16.57 | 36.55 | -118.59 | 1.48K | 10.66 | |||||
EBITA, 1 Yr. Growth % | 15 | 38.04 | -125.98 | 1.12K | 10.7 | |||||
EBIT, 1 Yr. Growth % | 15 | 38.04 | -125.98 | 1.12K | 10.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 61.25 | 32.95 | -49.27 | -529.88 | 56.02 | |||||
Net Income, 1 Yr. Growth % | 61.25 | 32.95 | -49.27 | -529.88 | 56.02 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.75 | 33.52 | -111.93 | 2.16K | 13.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 61.32 | 33.14 | -70.86 | -652.76 | 42.4 | |||||
Accounts Receivable, 1 Yr. Growth % | 256.25 | 4.61 | 11.53 | 49.25 | -48.11 | |||||
Inventory, 1 Yr. Growth % | 11.86 | 58.45 | 15.19 | 67.82 | 12.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 18.6 | 9.15 | 0 | -8.38 | -7.19 | |||||
Total Assets, 1 Yr. Growth % | 8.68 | 17.13 | 94.57 | -3.68 | -9.92 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.52 | 19.21 | 168.95 | -12.99 | -4.95 | |||||
Common Equity, 1 Yr. Growth % | 8.07 | 10.99 | 98.24 | -9.87 | -6.41 | |||||
Cash From Operations, 1 Yr. Growth % | -216.47 | -356.57 | -159.06 | 544 | 5.38 | |||||
Capital Expenditures, 1 Yr. Growth % | -13.95 | -21.62 | -44.83 | -87.5 | 300 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 888.04 | -149.67 | -60.96 | -1.58K | 5.05 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 882.61 | -152.99 | -60.96 | -1.58K | 5.05 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.09 | 22.72 | 9.78 | -39.58 | -28.05 | |||||
Gross Profit, 2 Yr. CAGR % | 11.08 | 18.6 | 6.14 | -41.66 | -32.78 | |||||
EBITDA, 2 Yr. CAGR % | 9.94 | 26.16 | -49.62 | 71.15 | 317.61 | |||||
EBITA, 2 Yr. CAGR % | 8.26 | 26 | -40.11 | 77.91 | 267.22 | |||||
EBIT, 2 Yr. CAGR % | 8.26 | 26 | -40.11 | 77.91 | 267.22 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.19 | 46.42 | -17.88 | 47.67 | 158.98 | |||||
Net Income, 2 Yr. CAGR % | 28.19 | 46.42 | -17.88 | 47.67 | 158.98 | |||||
Normalized Net Income, 2 Yr. CAGR % | 7.67 | 23.24 | -60.08 | 64.05 | 405.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 28.02 | 46.55 | -37.72 | 26.91 | 179.54 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.55 | 93.04 | 8.01 | 29.02 | -12 | |||||
Inventory, 2 Yr. CAGR % | 40.42 | 33.13 | 35.1 | 39.04 | 37.54 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 26.91 | 13.78 | 4.48 | -4.28 | -7.79 | |||||
Total Assets, 2 Yr. CAGR % | 4.62 | 12.82 | 50.96 | 36.9 | -6.85 | |||||
Tangible Book Value, 2 Yr. CAGR % | 12.54 | 16.84 | 79.06 | 52.97 | -9.06 | |||||
Common Equity, 2 Yr. CAGR % | 6.68 | 9.52 | 48.33 | 33.67 | -8.16 | |||||
Cash From Operations, 2 Yr. CAGR % |